Overview
The Cooper Companies, Inc. is a global medical-device company focused on vision, fertility, and women’s health through its CooperVision and CooperSurgical businesses. CooperVision develops and sells contact lenses, including specialty and myopia-management lenses; CooperSurgical offers fertility products and services alongside devices for gynecology and obstetrics. The company describes its purpose as helping people experience life’s beautiful moments and elevating standards of care in its markets.[1][2][3][4][5]
Cooper sells products in more than 130 countries. For fiscal 2025, it reported net sales of approximately $4.1 billion and had more than 15,000 employees as of October 31, 2025.[1][6][7] [1][2][3][4][5][6][7]
Products & services
CooperVision sells spherical, toric, multifocal and toric-multifocal contact lenses, including silicone-hydrogel products using Aquaform technology. Its named product families include daily-disposable clariti and MyDay, MyDay Energys, and frequent-replacement Biofinity and Avaira Vitality; Biofinity Energys is designed to help with digital eye fatigue. MiSight 1 day uses ActivControl technology, combining vision-correction and treatment zones, and is indicated to slow myopia progression in children whose treatment begins at ages 8–12. The portfolio also includes ActivControl lenses, orthokeratology and scleral lenses.[8][9][10][11]
CooperSurgical offers fertility products and services—including IVF media, devices and equipment, reproductive genomics, cryopreservation and cryostorage—as well as women’s-health medical devices, contraception, and cord-blood and cord-tissue storage. Paragard is a copper intrauterine device indicated to prevent pregnancy for up to 10 years.[12][13][14][15]
For the nine months ended July 31, 2026, CooperVision generated $2,135.6 million, or approximately 67.3% of company sales, and CooperSurgical generated $1,036.2 million, or approximately 32.7%. Within those businesses, toric/multifocal lenses accounted for $1,079.9 million and sphere/other lenses $1,055.7 million; CooperSurgical office/surgical products accounted for $624.6 million and fertility products $411.6 million. Percentages are calculated from reported sales.[16] [8][9][10][11][12][13][14][15][16][16][16][16][16][16][16][10][11][13][14][15]
Geographic presence
Cooper Companies is headquartered in San Ramon, California, and sells products in more than 130 countries. Its FY2025 net sales to unaffiliated customers were $2.054 billion in the United States (50.2%), $1.253 billion in Europe (30.6%), and $785.2 million in Rest of World, Other Eliminations & Corporate (19.2%), out of $4.092 billion total.[1][17] These are broad geographic-area figures; the filing does not provide a country-by-country sales breakdown.
CooperVision’s FY2025 regional sales were $1.124 billion in the Americas (41.0%), $1.064 billion in EMEA (38.8%), and $555.1 million in Asia Pacific (20.2%).[18] The company’s contact-lens manufacturing is concentrated primarily in Costa Rica, Hungary, Puerto Rico, the United Kingdom, and the United States, with smaller facilities elsewhere.[19][20] [1][17][17][17][17][18][18][18][19][20]
Business segments
For the fiscal year ended October 31, 2025, Cooper Companies reported two operating segments: CooperVision and CooperSurgical. CooperVision focuses on contact lenses, including products for astigmatism, presbyopia and myopia, as well as myopia-management and specialty eye-care products. It generated $2,743.8 million in net sales, approximately 67.1% of consolidated sales.[3][6]
CooperSurgical focuses on fertility and women’s health, with products and services including medical devices, cryostorage and contraception. It generated $1,348.6 million in net sales, approximately 32.9% of consolidated sales. The company presents corporate costs separately, not as a third operating segment.[5][6][21][2] [3][6][5][6][21][2]
Company history
CooperCompanies traces its roots to Martin H. Smith Co., a business acquired by Parker Montgomery in 1958. The company was renamed Cooper Laboratories in 1967 and reorganized into business units, including CooperVision, in 1978; CooperVision incorporated in 1980, and the company went public in 1983.[22][23][24] A secondary company-history account dates the change to The Cooper Companies name to 1987.[25]
A major expansion of CooperVision followed its 2005 merger with Ocular Sciences.[26][27] The company broadened its contact-lens business with the 2014 acquisition of Sauflon.[28] In 2015–17, CooperSurgical added reproductive-genetics and IVF businesses, including Reprogenetics, Research Instruments and Genesis Genetics; Cooper also acquired the PARAGARD IUD business and CooperVision acquired Paragon Vision Sciences.[29][30][31][32][33]
In 2018, Albert G. White III became president and CEO, succeeding Robert S. Weiss.[34][35] CooperVision’s MiSight 1 day received U.S. FDA approval in 2019, and CooperSurgical expanded into fertility services with the 2021 acquisition of Generate Life Sciences.[36][37] Cooper acquired obp Surgical in 2024, adding to CooperSurgical’s portfolio.[38] [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38]
Sources
- COOPER COMPANIES, INC. — Full financial report (2025 Y)
- COOPER COMPANIES, INC. — Full financial report (2026 Q 3)
- coopervision.com[10]
- coopervision.com[11]
- www.coopersurgical.com[13]
- www.coopersurgical.com[14]
- www.coopersurgical.com[15]
- www.coopervision.com[22]
- www.historyassociates.com[23]
- investor.coopercos.com[24]
- www.company-histories.com[25]
- investor.coopercos.com[26]
- investor.coopercos.com[27]
- coopervision.com[28]
- investor.coopercos.com[29]
- investor.coopercos.com[30]
- investor.coopercos.com[31]
- investor.coopercos.com[32]
- investor.coopercos.com[33]
- www.coopercos.com[34]
- www.coopercos.com[35]
- coopervision.com[36]
- investor.coopercos.com[37]
- investor.coopercos.com[38]
Continue your research
From company context to financial detail.
Explore original sources and worldwide fundamental financial data and intelligence with Finbar.
Explore COOPER COMPANIES, INC. in Finbar ↗